• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于通过压力定量吸入器增强肺部给药的纳米棒模板化开放絮状物。

Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.

作者信息

Engstrom Josh D, Tam Jasmine M, Miller Maria A, Williams Robert O, Johnston Keith P

机构信息

Department of Chemical Engineering, The University of Texas at Austin, Austin, Texas 78712, USA.

出版信息

Pharm Res. 2009 Jan;26(1):101-17. doi: 10.1007/s11095-008-9707-z. Epub 2008 Aug 29.

DOI:10.1007/s11095-008-9707-z
PMID:18758922
Abstract

PURPOSE

A novel concept is presented for the formation of stable suspensions composed of low density flocs of high aspect ratio drug particles in hydrofluoroalkane (HFA) propellants, and for subdividing (templating) the flocs with aerosolized HFA droplets to achieve high fine particle fractions with a pressurized metered dose inhaler.

METHODS

Bovine serum albumin (BSA) nanorods, produced by thin film freezing (TFF), were added to HFA to form a suspension. Particle properties were analyzed with an Anderson cascade impactor (ACI), static and dynamic light scattering and optical microscopy.

RESULTS

The space filling flocs in HFA were stable against settling for one year. The pMDI produced high fine particle fractions (38-47%) with an emitted dose of 0.7 mg/actuation. The atomized HFA droplets break apart, that is template, the highly open flocs. Upon evaporation of HFA, capillary forces shrink the templated flocs to produce porous particles with optimal aerodynamic diameters for deep lung delivery.

CONCLUSIONS

Open flocs composed of nanorods, stable against settling, may be templated during actuation with a pMDI to produce optimal aerodynamic diameters and high fine particle fractions. This concept is applicable to a wide variety of drugs without the need for surfactants or cosolvents to stabilize the primary particles.

摘要

目的

提出了一种新的概念,用于在氢氟烷烃(HFA)推进剂中形成由高纵横比药物颗粒的低密度絮凝物组成的稳定悬浮液,并通过雾化的HFA液滴对絮凝物进行细分(模板化),以通过定量压力吸入器实现高细颗粒分数。

方法

将通过薄膜冷冻(TFF)制备的牛血清白蛋白(BSA)纳米棒添加到HFA中以形成悬浮液。使用安德森级联撞击器(ACI)、静态和动态光散射以及光学显微镜分析颗粒性质。

结果

HFA中的空间填充絮凝物在一年内沉降稳定。定量压力吸入器产生了高细颗粒分数(38-47%),每次喷射剂量为0.7毫克。雾化的HFA液滴会分裂,即模板化高度开放的絮凝物。HFA蒸发后,毛细管力使模板化的絮凝物收缩,以产生具有适合深部肺部给药的最佳空气动力学直径的多孔颗粒。

结论

由纳米棒组成的开放絮凝物,沉降稳定,在使用定量压力吸入器启动过程中可进行模板化,以产生最佳空气动力学直径和高细颗粒分数。这一概念适用于多种药物,无需表面活性剂或助溶剂来稳定初级颗粒。

相似文献

1
Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.用于通过压力定量吸入器增强肺部给药的纳米棒模板化开放絮状物。
Pharm Res. 2009 Jan;26(1):101-17. doi: 10.1007/s11095-008-9707-z. Epub 2008 Aug 29.
2
Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers.用于加压定量吸入器肺部递送的各向异性颗粒的模板化开放絮团。
J Pharm Sci. 2010 Jul;99(7):3150-65. doi: 10.1002/jps.22091.
3
Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.推进剂组成对压力定量吸入器药物递送的影响。
Drug Dev Ind Pharm. 1998 Aug;24(8):763-70. doi: 10.3109/03639049809082724.
4
Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI.对一些市售的用于从压力定量吸入器递送糖皮质激素的间隔装置的研究。
Drug Dev Ind Pharm. 2001 May;27(5):401-12. doi: 10.1081/ddc-100104315.
5
The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.雾化初始液滴大小对压力定量吸入器残留颗粒大小的影响。
Int J Pharm. 2013 Oct 15;455(1-2):57-65. doi: 10.1016/j.ijpharm.2013.07.061. Epub 2013 Aug 1.
6
The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.氯氟烃向氢氟烷烃的转变:对压力定量吸入器悬浮液稳定性的影响。
J Allergy Clin Immunol. 1999 Dec;104(6):S221-6. doi: 10.1016/s0091-6749(99)70034-5.
7
Moisture uptake and its influence on pressurized metered-dose inhalers.水分吸收及其对压力定量吸入器的影响。
Pharm Dev Technol. 2000;5(2):153-62. doi: 10.1081/pdt-100100530.
8
Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants.用于将小极性药物和生物分子分散在氢氟烷烃推进剂中的核壳颗粒。
Pharm Res. 2008 Feb;25(2):289-301. doi: 10.1007/s11095-007-9466-2. Epub 2007 Oct 17.
9
Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.沙丁胺醇氯氟烃和氢氟烷烃-134a制剂在人体气道模型中的呼吸道沉积模式。
J Aerosol Med. 2001 Summer;14(2):255-66. doi: 10.1089/08942680152484180.
10
Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.湿度会影响丙酸倍氯米松压力定量吸入器所释放颗粒的形态。
Int J Pharm. 2017 Mar 30;520(1-2):207-215. doi: 10.1016/j.ijpharm.2017.01.062. Epub 2017 Feb 3.

引用本文的文献

1
Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations.用于干粉吸入制剂的薄膜冷冻技术进展
Pharmaceutics. 2022 Nov 28;14(12):2632. doi: 10.3390/pharmaceutics14122632.
2
Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects.制备柚皮苷纳米混悬液及其镇咳祛痰作用。
Molecules. 2022 Jan 24;27(3):741. doi: 10.3390/molecules27030741.
3
Respirable low-density microparticles formed in situ from aerosolized brittle matrices.可吸入的低密度微颗粒由气溶胶化的脆性基质原位形成。

本文引用的文献

1
Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution.用于增强肺部沉积和溶解的无定形环孢素纳米分散体。
J Pharm Sci. 2008 Nov;97(11):4915-33. doi: 10.1002/jps.21367.
2
Formation of stable submicron protein particles by thin film freezing.通过薄膜冷冻法形成稳定的亚微米蛋白质颗粒。
Pharm Res. 2008 Jun;25(6):1334-46. doi: 10.1007/s11095-008-9540-4.
3
Long acting porous microparticle for pulmonary protein delivery.用于肺部蛋白质递送的长效多孔微粒。
Pharm Res. 2013 Mar;30(3):813-25. doi: 10.1007/s11095-012-0922-2. Epub 2012 Nov 15.
4
Controlled delivery systems: from pharmaceuticals to cells and genes.控释给药系统:从药物到细胞和基因。
Pharm Res. 2011 Jun;28(6):1241-58. doi: 10.1007/s11095-011-0392-y. Epub 2011 Mar 19.
5
Building membrane emulsification into pulmonary drug delivery and targeting.将膜乳化技术应用于肺部药物递送与靶向
Pharm Res. 2010 Nov;27(11):2505-8. doi: 10.1007/s11095-010-0240-5. Epub 2010 Aug 12.
Int J Pharm. 2007 Mar 21;333(1-2):5-9. doi: 10.1016/j.ijpharm.2007.01.016. Epub 2007 Jan 19.
4
Inhaling medicines: delivering drugs to the body through the lungs.吸入药物:通过肺部将药物输送到体内。
Nat Rev Drug Discov. 2007 Jan;6(1):67-74. doi: 10.1038/nrd2153.
5
Particle size analysis in pharmaceutics: principles, methods and applications.制药学中的粒度分析:原理、方法与应用
Pharm Res. 2007 Feb;24(2):203-27. doi: 10.1007/s11095-006-9146-7. Epub 2006 Dec 27.
6
In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.压力定量吸入器药物颗粒相互作用和气溶胶性能的体外研究
Pharm Res. 2007 Jan;24(1):125-35. doi: 10.1007/s11095-006-9130-2. Epub 2006 Nov 14.
7
Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen.通过喷雾冷冻至液氮中制备的具有稳定高表面积的乳酸脱氢酶颗粒。
Eur J Pharm Biopharm. 2007 Feb;65(2):163-74. doi: 10.1016/j.ejpb.2006.08.002. Epub 2006 Aug 17.
8
Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure.HFA134a-水界面的微观和热力学性质:压力下的原子计算机模拟与张力测量
Langmuir. 2006 Oct 10;22(21):8826-30. doi: 10.1021/la0608157.
9
Morphology of protein particles produced by spray freezing of concentrated solutions.浓缩溶液喷雾冷冻产生的蛋白质颗粒的形态学
Eur J Pharm Biopharm. 2007 Feb;65(2):149-62. doi: 10.1016/j.ejpb.2006.08.005. Epub 2006 Aug 18.
10
Electrostatically stabilized metal oxide particle dispersions in carbon dioxide.二氧化碳中静电稳定的金属氧化物颗粒分散体。
J Phys Chem B. 2005 Nov 3;109(43):20155-65. doi: 10.1021/jp0532521.